,

NDFS13 BARDA Presentation: Partnering with the Biomedical Advanced Research and Development Authority

Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck

/0 Comments/by
You might also like
NDFS17 BARDANDFS17 Video: Non-dilutive funding at BARDA for medical countermeasure R&D
Non-dilutive funding leads to equity investmentHow Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech BioIs Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
BARDA Coronavirus Countermeasures Portfolio
Non-Dilutive Funding Mega-Panel: The Relationship Between Industry and Non-Dilutive Sources
NDFS17 NINDSNDFS17 Video: NINDS Funding Programs for Translational Research in Neuroscience
Join hundreds of life science industry leaders at The 18th Annual Non-Dilutive Funding Summit (NDFS) and find out more about non-dilutive funding for your R&D, including funding opportunities through The Biomedical Advanced Research and Development Authority (BARDA).BARDA Returns to NDFS
Available Online: Non-Dilutive Funding Opportunities Beyond the SBIR
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *